Terminal differentiation program of CD8 T cells guides immunotherapeutic options for CLL patients.

Camerini E, Montironi C, Quik M, Dijkema M, Dekkers F, Mes MJ, Magnée C, Cretenet G, Remmerswaal EBM, Simon-Molas H, Noll JH, Fraietta JA, Hoogendoorn M, Schreurs R, Ribeiro C, Eldering E, Amsen D, Kater AP, Peters FS

Open source

DOI: 10.1182/blood.2026035207
Published: 2026 Nov 9
Container: Blood
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2026035207,
  title = {Terminal differentiation program of CD8 T cells guides immunotherapeutic options for CLL patients.},
  author = {Camerini E and Montironi C and Quik M and Dijkema M and Dekkers F and Mes MJ and Magnée C and Cretenet G and Remmerswaal EBM and Simon-Molas H and Noll JH and Fraietta JA and Hoogendoorn M and Schreurs R and Ribeiro C and Eldering E and Amsen D and Kater AP and Peters FS},
  year = {2026},
  journal = {Blood},
  doi = {10.1182/blood.2026035207},
  url = {https://doi.org/10.1182/blood.2026035207}
}

RIS

TY  - JOUR
TI  - Terminal differentiation program of CD8 T cells guides immunotherapeutic options for CLL patients.
AU  - Camerini E
AU  - Montironi C
AU  - Quik M
AU  - Dijkema M
AU  - Dekkers F
AU  - Mes MJ
AU  - Magnée C
AU  - Cretenet G
AU  - Remmerswaal EBM
AU  - Simon-Molas H
AU  - Noll JH
AU  - Fraietta JA
AU  - Hoogendoorn M
AU  - Schreurs R
AU  - Ribeiro C
AU  - Eldering E
AU  - Amsen D
AU  - Kater AP
AU  - Peters FS
PY  - 2026
JO  - Blood
DO  - 10.1182/blood.2026035207
UR  - https://doi.org/10.1182/blood.2026035207
ER  -

APA

E, C., C, M., M, Q., M, D., F, D., MJ, M., C, M., G, C., EBM, R., H, S., JH, N., JA, F., M, H., R, S., C, R., E, E., D, A., AP, K., & FS, P. (2026). Terminal differentiation program of CD8 T cells guides immunotherapeutic options for CLL patients.. Blood. https://doi.org/10.1182/blood.2026035207

Source records

pubmed · retrieved 2026-11-10T12:05:08.256Z